|
Irresponsibility does not warrant a death sentence, and financial capabilities should not be a factor.
If an African fucked up, then that's that. But if an African who fucked up can also afford at-cost produced pills and American drug companies hold out on him because he can't afford at-cost + profit they choose, then I've got no problems if they miss out on entire national markets due to companies infringing on their patents and selling affordable treatments.
And if that recourse should stifle innovation, I ask again: What's more profitable, treating an illness or curing it?
|